Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 07, 2026
TickeronGET DAILY SIGNALS
CRM Down -13% YTD vs. CRWD Up +85%: Weighing Salesforce Against CrowdStrike

CRM Down -13% YTD vs. CRWD Up +85%: Weighing Salesforce Against CrowdStrike

Key Takeaways

  • Tickeron AI Verdict: CRWD stands out in this matchup, thanks to steadier trend consistency and stronger relative momentum.
  • CRM is a profitable software leader with revenue growth near 10%, while CRWD is a high-growth cybersecurity name expanding at roughly 26%.
  • CRM’s Agentforce AI platform has topped $1.5 billion in annual recurring revenue (ARR), while CRWD continues to benefit from AI-driven demand for its Falcon security platform.
  • CRM trades near 21 times earnings and is down roughly 13% year-to-date (YTD), whereas CRWD is up about 85% YTD but has pulled back from recent highs amid valuation concerns.
  • Explore more via CRM Major News and CRM Today's Price Move, as well as CRWD Major News and CRWD Today's Price Move.
  • To see how automated strategies are positioning across the market, explore Trending AI Robots.

Setting the Stage: Two Distinct Tech Paths

Salesforce (CRM) and CrowdStrike (CRWD) remain two of the most closely watched names in enterprise software, though they operate in quite different segments. CRM dominates customer relationship management software, while CRWD leads in cloud-native cybersecurity. This comparison matters for growth investors balancing a profitable software incumbent against a faster-expanding security platform, and for traders assessing relative performance and market positioning. Both are positioning themselves as key AI beneficiaries, yet their paths and risk profiles differ in important ways. I also checked this using Tickeron’s AI Screener to see how the stocks compare within their respective industries.

A Closer Look at Salesforce (CRM)

Salesforce is the world’s largest provider of CRM software, supporting enterprises with sales, service, marketing, and data tools through its Customer 360 platform, which includes Slack and Tableau. Recent attention has focused on Agentforce, its platform for building autonomous AI agents. Agentforce ARR has surpassed $1.5 billion, up more than 240% year over year, and together with Data 360 it approaches roughly $3.9 billion.

The company has raised its full-year revenue guidance and completed acquisitions of Contentful and Fin, while strengthening its partnership with Anthropic. Even so, CRM shares have shown volatility. The stock recently traded near $228, with a market capitalization around $190 billion, a trailing P/E ratio near 21, and a 52-week range between roughly $146 and $269. CRM is down about 13% YTD but has rebounded over the trailing three months as investors reassess its AI monetization path.

A Closer Look at CrowdStrike (CRWD)

CrowdStrike delivers cloud-based cybersecurity via its Falcon platform, covering endpoint protection, identity security, cloud security, and managed detection and response. Demand has picked up as organizations expand their AI footprint, which management describes as an expanding attack surface. In recent quarters, revenue grew roughly 26% year over year to about $1.4 billion per quarter, and ARR reached approximately $5.5 billion, up about 24%.

CRWD completed a 4-for-1 stock split and has been among the stronger performers in software, returning roughly 85% YTD and more than 60% over the trailing year. The stock recently traded near $217 with a market capitalization around $222 billion. Momentum has cooled somewhat, with CRWD pulling back about 10% from its October high on AI-regulation concerns and sector-wide profit-taking. Its valuation remains elevated, with a P/E ratio in the thousands reflecting minimal net income, though the company is approaching operating breakeven. Recent acquisitions of Fiddler and Dreadnode highlight its push into AI security and observability. From what I see, the growth trajectory here remains compelling.

Side-by-Side Comparison

The companies differ most on growth, profitability, and valuation. CRWD delivers roughly 26% revenue growth versus about 10% for CRM, reflecting cybersecurity’s more defensive, mission-critical demand. Yet CRM is highly profitable, generating billions in net income and returning cash through buybacks and a dividend, while CRWD still reports only marginal net income and remains near operating breakeven.

Sector exposure also varies. CRM is tied to enterprise IT budgets and discretionary software spending, which has made it more sensitive to AI-disruption fears. CRWD benefits from security spending that tends to be more resilient, and its Falcon Flex consumption model supports cross-selling across modules. On valuation, CRM’s P/E near 21 is far more modest than CRWD’s triple-digit sales multiple, meaning CRWD carries higher expectations and greater downside sensitivity to any growth disappointment. In recent market activity, CRM has been the recovery story, while CRWD has been the momentum story giving back some gains. I’m watching this closely as earnings season approaches.

Tickeron AI Verdict

Based on observable factors such as trend consistency, relative momentum, growth trajectory, and positioning, Tickeron’s AI would currently lean toward CRWD. The stock’s sustained upward trend over the trailing year, accelerating ARR, and leadership in AI-native security suggest a more consistent directional signal than CRM’s choppier, valuation-driven recovery. That said, CRWD’s elevated multiple and recent pullback introduce meaningful volatility risk, while CRM’s profitability and lower valuation provide a more defensive profile. This assessment reflects a probabilistic reading of current data rather than a definitive forecast, and relative positioning could shift as either company reports earnings or as market sentiment evolves.

Exploring Automated Strategies

In my regular research, I often review Tickeron’s AI Trading Bots to understand how different automated approaches are positioned across the market right now. These bots cover thousands of tickers with varying styles, timeframes, and performance records, and the curated trending list helps highlight which strategies align best with current conditions. Whether evaluating CRM, CRWD, or a broader list, this data-driven view adds useful context to manual analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CRM, CRWD

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CRM's RSI Oscillator stoops into oversold zone

The RSI Indicator for CRM moved into overbought territory on November 06, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRM advanced for three days, in 222 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

CRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRM as a result. In 60 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for CRM turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 33 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

CRM moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CRM crossed bearishly below the 50-day moving average on November 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 59%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.

The Aroon Indicator for CRM entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. CRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.582) is normal, around the industry mean (-1.942). P/E Ratio (19.529) is within average values for comparable stocks, (15.235). Projected Growth (PEG Ratio) (0.759) is also within normal values, averaging (2.824). Dividend Yield (0.008) settles around the average of (0.069) among similar stocks. P/S Ratio (5.107) is also within normal values, averaging (70.854).

The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.36B. The market cap for tickers in the group ranges from 39 to 269.45B. SAP holds the highest valuation in this group at 269.45B. The lowest valued company is STIXF at 39.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was -2%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -5%. IFBD experienced the highest price growth at 115%, while NTCL experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 34%. For the same stocks of the Industry, the average monthly volume growth was 28% and the average quarterly volume growth was -22%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 58
Price Growth Rating: 60
SMR Rating: 77
Profit Risk Rating: 93
Seasonality Score: 13 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of on-demand customer relationship management software technology

Industry PackagedSoftware

Industry
Packaged Software
Address
415 Mission Street
Phone
+1 415 901-7000
Employees
83334
Web
https://www.salesforce.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of $1.54 billion, reflecting approximately 74% year-over-year growth. Consensus earnings per share (EPS) forecast stands at $0.28, up over 115% from the prior year.
Analysts expect Q1 2026 revenue of $3.00 billion, up 8% from $2.77 billion in the year-ago quarter. Consensus earnings per share (EPS) estimate stands at $4.31, reflecting steady profitability from the cystic fibrosis (CF) portfolio.